Sigilon Therapeutics Inc (SGTX)
US$ 3.930%
Price Chart
Key Statistics
Market Cap
$ 56.22M
P/E Ratio
0.00
Revenue (TTM)
$ 17.65M
Volume
10.43K
52W High
$ 0.00
52W Low
$ 0.00
Dividend Yield
0.00%
Beta
4.12
Technicals
50-Day MA
17.3509
200-Day MA
10.359
52 Week High
N/A
52 Week Low
N/A
About SGTX
Sigilon Therapeutics, Inc., a preclinical stage biotechnology company, develops functional cures for patients with acute and chronic diseases.
Employees
62
Headquarters
Cambridge, MA
CEO
Dr. Rogerio Vivaldi Coelho M.B.A., M.D., MBA
Latest News
Sigilon Announces Reverse Stock Split of Common Stock - GlobeNewswire
2023-05-22 • Google News
Eli Lilly to Acquire Sigilon Therapeutics - Investopedia
2023-06-29 • Google News
Top Gainers
Symbol/Name
LTP
% Chg
Top Losers
Symbol/Name
LTP
% Chg